Parties
Identify each legal entity by exact legal name, business address, and contact for compliance notices; include DBA names where applicable to avoid identity confusion in enforcement.
These agreements reduce diversion risk by formalizing permitted distribution channels, information-sharing, and audit rights while creating contractual remedies for noncompliance and aligning partners with regulatory expectations under ESIGN/UETA for electronic records.
Execution often requires signatory authority from compliance or executive leadership and may require a notary or witness depending on jurisdictional or customer requirements.
Identify each legal entity by exact legal name, business address, and contact for compliance notices; include DBA names where applicable to avoid identity confusion in enforcement.
List products precisely by SKU, lot, or NDC numbers where applicable, and include any excluded items so enforcement and monitoring focus on the intended inventory.
Define allowed distribution paths, authorized resellers, and geographic or customer restrictions to reduce ambiguity about where and to whom products may be sold.
Set audit rights, data exchange obligations, frequency of inventory reconciliation, and required reporting windows for suspected diversion or anomalies.
Specify contract remedies, suspension rights, indemnities, and conditions for termination or recall to enable rapid response to confirmed diversion events.
Include data protection, permitted use of monitoring reports, and any HIPAA or other privacy safeguards when product or patient data is involved.
| Field Mapping | Create named form fields for signature, date, and product lists. |
|---|---|
| Conditional Logic | Show audit or reporting sections only for specified product types. |
| Authentication Level | Select email, SMS code, or advanced ID verification based on risk. |
| Template Saving | Save a reusable template for repeat partner agreements. |
| Audit Trail | Ensure automatic capture of IP, timestamps, and signer actions. |
Maintaining secure records, an immutable audit trail, and integration paths reduces friction for future audits or regulatory requests.
7–14 days for initial legal and compliance review
30 days from initial transmission is common
Many firms set 24–72 hour reporting for suspected diversion
Quarterly or annual reconciliations are typical
Retention periods begin on the agreement effective date
A distributor implements product-level tracking and quarterly reconciliations
A manufacturer requires authorized channel lists and real-time shipment visibility
Chief compliance or regulatory affairs officers typically review and approve anti-diversion clauses and have operational authority to require monitoring. Their signature or written authorization ensures the entity is bound and can implement required controls.
A named corporate officer (e.g., VP, General Counsel, CFO) with signing authority should execute the agreement to bind the legal entity and enable enforcement against counterparties when breaches occur.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | None | 100 envelopes/user/year | Varies by plan | Varies by plan | Varies by plan |